BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 28686127)

  • 1. Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.
    Yang W; Xu R; Porras JL; Takemoto CM; Khalid S; Garzon-Muvdi T; Caplan JM; Colby GP; Coon AL; Tamargo RJ; Huang J; Ahn ES
    J Neurosurg Pediatr; 2017 Sep; 20(3):232-238. PubMed ID: 28686127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
    Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
    J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral Revascularization for Moyamoya Syndrome Associated with Sickle Cell Disease: A Systematic Review of the Literature on the Role of Extracranial-Intracranial Bypass in Treating Neurologic Manifestations of Pediatric Patients with Sickle Cell Disease.
    Terrell D; Savardekar AR; Whipple SG; Dossani RH; Spetzler RF; Sun H
    World Neurosurg; 2020 May; 137():62-70. PubMed ID: 32014541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical Revascularization for Pediatric Patients with Sickle Cell Disease and Moyamoya Disease in the Prevention of Ischemic Strokes: A Single-Center Case Series and a Systematic Review.
    Aguilar-Salinas P; Hayward K; Santos R; Agarwal V; Sauvageau E; Hanel RA; Aldana PR
    World Neurosurg; 2019 Mar; 123():435-442.e8. PubMed ID: 30496928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral revascularization surgery reduces cerebrovascular events in children with sickle cell disease and moyamoya syndrome: Results of the stroke in sickle cell revascularization surgery retrospective study.
    Aldana PR; Hanel RA; Piatt J; Han SH; Bansal MM; Schultz C; Gauger C; Pederson JM; Iii JCW; Hulbert ML; Jordan LC; Qureshi A; Garrity K; Robert AP; Hatem A; Stein J; Beydler E; Adelson PD; Greene S; Grabb P; Johnston J; Lang SS; Leonard J; Magge SN; Scott A; Shah S; Smith ER; Smith J; Strahle J; Vadivelu S; Webb J; Wrubel D
    Pediatr Blood Cancer; 2023 Jul; 70(7):e30336. PubMed ID: 37057741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical Treatment for Patients with Moyamoya Syndrome and Type 1 Neurofibromatosis.
    Porras JL; Yang W; Garzon-Muvdi T; Xu R; Blakeley J; Belzberg A; Caplan JM; Khalid S; Colby GP; Coon AL; Tamargo RJ; Ahn ES; Huang J
    World Neurosurg; 2017 Mar; 99():19-25. PubMed ID: 27876659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of encephalo-myo-synangiosis in surgical revascularization strategies for moyamoya disease in children and adults.
    Imai H; Miyawaki S; Ono H; Nakatomi H; Yoshimoto Y; Saito N
    World Neurosurg; 2015 May; 83(5):691-9. PubMed ID: 25655688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.
    Smith ER; McClain CD; Heeney M; Scott RM
    Neurosurg Focus; 2009 Apr; 26(4):E10. PubMed ID: 19335126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
    Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
    J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encephaloduroateriosynangiosis (EDAS) in the management of Moyamoya syndrome in children with sickle cell disease.
    Alamri A; Hever P; Cheserem J; Gradil C; Bassi S; Tolias CM
    Br J Neurosurg; 2019 Apr; 33(2):161-164. PubMed ID: 28616936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pial synangiosis for moyamoya syndrome in children with sickle cell anemia: a comprehensive review of reported cases.
    Kennedy BC; McDowell MM; Yang PH; Wilson CM; Li S; Hankinson TC; Feldstein NA; Anderson RC
    Neurosurg Focus; 2014 Jan; 36(1):E12. PubMed ID: 24380478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down syndrome and moyamoya: clinical presentation and surgical management.
    See AP; Ropper AE; Underberg DL; Robertson RL; Scott RM; Smith ER
    J Neurosurg Pediatr; 2015 Jul; 16(1):58-63. PubMed ID: 25837890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults.
    Jang DK; Lee KS; Rha HK; Huh PW; Yang JH; Park IS; Ahn JG; Sung JH; Han YM
    J Neurosurg; 2017 Sep; 127(3):492-502. PubMed ID: 27834597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.
    Pandey P; Steinberg GK
    J Neurosurg; 2011 Aug; 115(2):328-36. PubMed ID: 21529138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes in Patients with Moyamoya Syndrome and Sickle Cell Disease: A Systematic Review.
    Newman S; Boulter JH; Malcolm JG; Pradilla I; Pradilla G
    World Neurosurg; 2020 Mar; 135():165-170. PubMed ID: 31790841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct Clinical and Radiographic Phenotypes in Pediatric Patients With Moyamoya.
    Kaseka ML; Slim M; Muthusami P; Dirks PB; Westmacott R; Kassner A; Bhathal I; Williams S; Shroff M; Logan W; Moharir M; MacGregor DL; Pulcine E; deVeber GA; Dlamini N
    Pediatr Neurol; 2021 Jul; 120():18-26. PubMed ID: 33962345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "STA-MCA bypass with encephalo-duro-myo-synangiosis combined with bifrontal encephalo-duro-periosteal-synangiosis" as a one-staged revascularization strategy for pediatric moyamoya vasculopathy.
    Esposito G; Kronenburg A; Fierstra J; Braun KP; Klijn CJ; van der Zwan A; Regli L
    Childs Nerv Syst; 2015 May; 31(5):765-72. PubMed ID: 25722049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization.
    Jea A; Smith ER; Robertson R; Scott RM
    Pediatrics; 2005 Nov; 116(5):e694-701. PubMed ID: 16263984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encephaloduroarteriosynangiosis (EDAS) in young patients with cerebrovascular complications of sickle cell disease: Single-institution experience.
    Winstead M; Sun PP; Martin K; Earl J; Neumayr L; Hoppe C; Vichinsky E
    Pediatr Hematol Oncol; 2017 Mar; 34(2):100-106. PubMed ID: 28532265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective surgical revascularization improves cerebral hemodynamics and resolves headache in pediatric Moyamoya disease.
    Kawabori M; Kuroda S; Nakayama N; Hirata K; Shiga T; Houkin K; Tamaki N
    World Neurosurg; 2013 Nov; 80(5):612-9. PubMed ID: 23022638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.